JAGX offering history
Every offering-related filing in Jaguar Health, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Jan 29, 2016.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 27, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 27, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 24, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 24, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 24, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 16, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jul 16, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jun 18, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 11, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 2, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 19, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 23, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 12, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 12, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 12, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 25, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 25, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 19, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 3, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 3, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 1, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 11, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 14, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 30, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 24, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 30, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 27, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 27, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 27, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 24, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 20, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 22, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 22, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 21, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 15, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 7, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 7, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 5, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 2, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
JAGX offering FAQ
When did JAGX last execute an offering?
Per SEC filings, Jaguar Health, Inc.'s most recent priced offering document is a 8-K filed 2026-06-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did JAGX last announce or register an offering?
The most recent registration is a S-1/A filed 2026-07-24. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.